Spondylarthritis
|
|
0.010 |
GeneticVariation
|
BEFREE |
rs6908425 T>C in CDKAL1 was significantly different between SAPHO cases and healthy controls (odds ratios = 2.056, 95% confidence intervals: 1.211-3.490; p = 0.007), but no SNPs were associated with the risk of developing RA, AS, or SPA (p > 0.05).
|
27936930 |
2017 |
Rheumatoid Arthritis
|
|
0.010 |
GeneticVariation
|
BEFREE |
rs6908425 T>C in CDKAL1 was significantly different between SAPHO cases and healthy controls (odds ratios = 2.056, 95% confidence intervals: 1.211-3.490; p = 0.007), but no SNPs were associated with the risk of developing RA, AS, or SPA (p > 0.05).
|
27936930 |
2017 |
Osteitis
|
|
0.010 |
GeneticVariation
|
BEFREE |
Our results suggest that rs6908425 in CDKAL1 is associated with the risk of developing SAPHO in Han Chinese populations.
|
27936930 |
2017 |
Spondylarthropathies
|
|
0.010 |
GeneticVariation
|
BEFREE |
rs6908425 T>C in CDKAL1 was significantly different between SAPHO cases and healthy controls (odds ratios = 2.056, 95% confidence intervals: 1.211-3.490; p = 0.007), but no SNPs were associated with the risk of developing RA, AS, or SPA (p > 0.05).
|
27936930 |
2017 |
Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome
|
|
0.010 |
GeneticVariation
|
BEFREE |
People who carry the risk allele T of rs6908425 might be more prone to developing SAPHO syndrome.
|
27936930 |
2017 |
Ankylosing spondylitis
|
|
0.010 |
GeneticVariation
|
BEFREE |
The current study evaluated whether three previously reported AS-associated single-nucleotide polymorphisms (SNPs), rs6908425 T>C in CDKAL1, rs11584383 T>C near KIF21B, and rs11175593 C>T near LRRK2/MUC19, have any genetic overlap across multiple autoimmune diseases including SAPHO syndrome, RA, AS, and SPA.
|
27936930 |
2017 |
Psoriasis
|
|
0.010 |
GeneticVariation
|
BEFREE |
With this study, we validate this association, through the analysis of CDKAL1 single nucleotide polymorphism (SNP) rs6908425 in an independently ascertained psoriasis dataset (replication sample: 1323 cases vs 1368 controls, P=0.00012, odds ratio (OR): 1.28; combined sample: 2579 cases vs 4306 controls, P=4 x 10(-6), OR: 1.26).
|
19587699 |
2009 |
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation
|
BEFREE |
Notably, the marker showing the strongest phenotypic effect (rs6908425) maps to CDKAL1, a gene also associated with type 2 diabetes.
|
17993580 |
2008 |